Preview

PULMONOLOGIYA

Advanced search

Airway microbial landscape in patients with primary ciliary dyskinesia – a pilot study

https://doi.org/10.18093/0869-0189-2024-4446

Abstract

Primary ciliary dyskinesia (PCD) is a rare hereditary disease belonging to the group of ciliopathies. PCD is caused by a defect in the ultrastructure of the cilia of the respiratory epithelium and similar structures (sperm flagella, fallopian tube villi, ventricular ependyma) with a prevalence of 1:10,000 to 1:30,000 people. One of the main problems associated with this condition is frequent recurrent bacterial infections, which lead to decreased lung function and the development of bronchiectasis.

The aim was to study the microbial landscape of the respiratory tract of patients with PCD.

Methods. We studied the medical history and bacteriological assays of 170 throat, nasal, and sputum samples from 64 patients diagnosed with PCD. virological studies on pathogens of acute respiratory viral infection, using polymerase chain reaction with reverse transcription, and MALDITOF mass spectrometry were used to identify microorganisms.

Results. The assay identified 46 bacterial species, 4 viral species, and representatives of 2 fungal genera. The predominant bacteria were Staphylococcus aureus (62.5%) and Pseudomonas aeruginosa (26.6%). The identified fungi were Candida spp. and Aspergillus spp. Viruses (Adenoviridae, Coronaviridae, Rhinoviridae) were detected in 7 patients in association with representatives of normal microflora and clinically significant microorganisms such as S. aureus, Klebsiella pneumoniae, P. aeruginosa. Achromobacter spp., Stenotrophomonas maltophilia, Acinetobacter spp., and Moraxella spp. were isolated in individual cases in patients of all age groups.

Conclusion. The respiratory microflora was characterized by a species diversity of pathogens and was mixed in 79.7% of patients. A viral-bacterial associations was observed in 10.9% of patients. S. aureus was the predominant pathogen in the group of children and adolescents (58.3% and 82.6%, respectively), whereas P. aeruginosa predominated (52.9%) in the adult patients.

About the Authors

M. Yu. Chernukha
Federal Government Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation”
Russian Federation

Marina Yu. Chernukha, Doctor of Medicine, Head of the Laboratory of Epidemiology of Nosocomial Infections

Ul. Gamaleya 18, Moscow, 123098; tel.: (499) 193-61-17


Competing Interests:

There is no conflict of interest



E. I. Kondratyeva
Federal State Budgetary Scientific Institution “Research Centre for Medical Genetics”, Ministry of Science and Higher Education of the Russian Federation
Russian Federation

Elena I. Kondratyeva - Doctor of Medicine, Professor, Head of the Scientific and Clinical Department of cystic fibrosis, Head of the Department of Genetics of Respiratory System Diseases, Institute of Higher and Additional Professional Education.

ul. Moskvorechye 1, Moscow, 115522; Scopus ID: 36737150600; tel.: (495) 111-03-03


Competing Interests:

There is no conflict of interest



E. A. Domblides
Federal Government Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation”
Russian Federation

Edward A. Domblides - Junior Researcher, Laboratory of Epidemiology of Nosocomial Infections.

ul. Gamaleya 18, Moscow, 123098; tel.: (499) 193-55-94


Competing Interests:

There is no conflict of interest



L. R. Avetisyan
Federal Government Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F.Gamaleya of the Ministry of Health of the Russian Federation”
Russian Federation

Lusine R. Avetisyan - Doctor of Medicine, head of the Laboratory of epidemiology of opportunistic infections.

ul. Gamaleya 18, Moscow, 123098; tel.: (499) 193-55-94


Competing Interests:

There is no conflict of interest



A. Yu. Voronkova
Federal State Budgetary Scientific Institution “Research Centre for Medical Genetics”, Ministry of Science and Higher Education of the Russian Federation
Russian Federation

Anna Yu. Voronkova - Candidate of Medicine, Leading Researcher, Scientific and Clinical Department of Cystic Fibrosis.

ul. Moskvorechye 1, Moscow, 115522; tel.: (495) 111-03-03; Scopus ID: 57189352251


Competing Interests:

There is no conflict of interest



T. A. Kyian
Federal State Budgetary Scientific Institution “Research Centre for Medical Genetics”, Ministry of Science and Higher Education of the Russian Federation
Russian Federation

Tatiana A. Kyian - Candidate of Medicine, Senior Researcher, Scientific and Clinical Department of Cystic.

ul. Moskvorechye 1, Moscow, 115522; tel.: (499) 324-15-01; Scopus ID: 57205414678


Competing Interests:

There is no conflict of interest



V. G. Zhukhovitsky
Federal Government Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation”; Federal State Budgetary Educational Institution of Additional Professional Education “Russian Medical Academy of Continuous Professional Education”, Ministry of Health of Russia
Russian Federation

Vladimir G. Zhukhovitsky - Candidate of Medicine, Head of the Laboratory of Indication and Ultrastructural Analysis of Microorganisms; Associate Professor, Department Сlinical Laboratory Diagnostics with a course in Laboratory Immunology.

Ul. Gamaleya 18, Moscow, 123098; ul. Barrikadnaya 2/1, Moscow, 123995; tel.: (499) 193-43-76


Competing Interests:

There is no conflict of interest



N. B. Polyakov
Federal Government Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F.Gamaleya of the Ministry of Health of the Russian Federation”
Russian Federation

Nikita B. Polyakov - Researcher, Laboratory of Indication and Ultrastructural Analysis of Microorganisms.

Ul. Gamaleya 18, Moscow, 123098; tel.: (499) 190-74-22


Competing Interests:

There is no conflict of interest



E. I. Burtseva
Federal Government Budgetary Institution “National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F.Gamaleya of the Ministry of Health of the Russian Federation”
Russian Federation

Elena I. Burtseva - Doctor of Medicine, Head of Laboratory of Etiology and Epidemiology of Influenza.

Ul. Gamaleya 18, Moscow, 123098; tel.: (499) 193-55-94


Competing Interests:

There is no conflict of interest



References

1. Kondratyeva E.I., Avdeev S.N., Mizernitskiy Yu.L. et al. [Primary ciliary dyskinesia: review of the draft clinical guidelines, 2022]. Pul’monologiya. 2022; 32 (4): 517–538. DOI: 10.18093/0869-01892022-32-4-517-538 (in Russian).

2. Bogorad A.E., D’yakova S.E., Mizernitskiy Yu.L. [Primary ciliary dyskinesia: modern approaches to the diagnostics and treatment]. Rossiyskiy vestnik perinatologii i pediatrii. 2019; 64 (5): 123–133. DOI: 10.21508/1027-4065-2019-64-5-123-133 (in Russian).

3. Kuehni C.E, Lucas J.S. Diagnosis of primary ciliary dyskinesia: summary of the ERS Task Force report. Breathe (Sheff.). 2017; 13 (3): 166–178. DOI: 10.1183/20734735.008517.

4. Alanin M.C., Nielsen K.G., von Buchwald C. et al. A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia. Clin. Microbiol. Infect. 2015; 21 (12): 1093.e1–1093.e7. DOI: 10.1016/j.cmi.2015.08.020.

5. Cohen-Cymberknoh M., Weigert N., Gileles-Hillel A. et al. Clinical impact of pseudomonas aeruginosa colonization in patients with primary ciliary dyskinesia. Respir. Med. 2017; 131: 241–246. DOI: 10.1016/j.rmed.2017.08.028.

6. Chernukha M.Yu., Shaginyan I.A., Zhukhovitskiy V.G. et al. [Use of the MALDI Biotyper system and the microbiological diagnosis algorithm for identification of non-fermenting bacteria isolated from respiratory tract in cystic fibrosis patients]. Klinicheskaya mikrobiologiya i antimikrobnaya ximioterapiya. 2017; 19 (4): 327–334. Available at: https://cmac-journal.ru/publication/2017/4/cmac-2017-t19-n4-p327/cmac-2017-t19-n4-p327.pdf (in Russian).

7. Domonova E.A., Tvorogova M.G., Podkolzin A.T. et al. [Collection, transportation, storage of biological material for PCR diagnostics: methodological recommendations]. Moscow; 2021. Available at: https://prepcr.crie.ru/docs/Metodicheskie_Rekomendacii.pdf (in Russian).

8. Wijers C.D., Chmiel J.F., Gaston B.M. Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis. Chron. Respir. Dis. 2017; 14 (4): 392–406. DOI: 10.1177/1479972317694621.

9. Noone P.G., Leigh M.W., Sannuti A. et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am. J. Respir. Crit. Care Med. 2004; 169 (4): 459–467. DOI: 10.1164/rccm.200303-365OC.

10. Burmistrov E.M., Krasnoslobodtsev K.G., Avetisyan L.R. et al. [Mixed bacterial-viral lung infections in patients with cystic fibrosis]. Pul’monologiya. 2023; 33 (4): 488–496. DOI: 10.18093/0869-01892023 33-4-488-496 (in Russian).


Supplementary files

Review

For citations:


Chernukha M.Yu., Kondratyeva E.I., Domblides E.A., Avetisyan L.R., Voronkova A.Yu., Kyian T.A., Zhukhovitsky V.G., Polyakov N.B., Burtseva E.I. Airway microbial landscape in patients with primary ciliary dyskinesia – a pilot study. PULMONOLOGIYA. 2025;35(3):351-358. (In Russ.) https://doi.org/10.18093/0869-0189-2024-4446

Views: 313


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)